Skip to main content
Top
Published in: European Radiology 8/2020

Open Access 01-08-2020 | Radiological Education

How to avoid describing your radiological research study incorrectly

Authors: Steve Halligan, Shedrack F. Kenis, Oshaani Abeyakoon, Andrew A. O. Plumb, Susan Mallett

Published in: European Radiology | Issue 8/2020

Login to get access

Abstract

This review identifies and examines terms used to describe a radiological research “study” or “trial”. A taxonomy of clinical research descriptions is explained with reference to medical imaging examples. Because many descriptive terms have precise methodological implications, it is important that these terms are understood by readers and used correctly by researchers, so that the reader is not misled.

Key Points

• Multiple different terms are being used to describe radiological research “studies” and “trials”, and many of these terms have precise methodological implications.
• Radiological researchers sometimes use titles that describe their research incorrectly. This can mislead the reader as to what was actually done.
• It is important that readers and researchers understand the correct taxonomy of clinical research and that researchers adopt the correct description for their work.
Literature
3.
go back to reference Arain M, Campbell MJ, Cooper CL, Lancaster GA (2010) What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol 10:67PubMedPubMedCentral Arain M, Campbell MJ, Cooper CL, Lancaster GA (2010) What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol 10:67PubMedPubMedCentral
4.
go back to reference Olsen M, Zhelev Z, Hunt H, Peters JL, Bossuyt P, Hyde C (2019) Use of test accuracy study design labels in NICE’s diagnostic guidance. Diagn Progn Res 3:17PubMedPubMedCentral Olsen M, Zhelev Z, Hunt H, Peters JL, Bossuyt P, Hyde C (2019) Use of test accuracy study design labels in NICE’s diagnostic guidance. Diagn Progn Res 3:17PubMedPubMedCentral
5.
go back to reference Ryuge M, Hara M, Hiroe T et al (2019) Mechanisms of recurrent haemoptysis after super-selective bronchial artery coil embolisation: a single-centre retrospective observational study. Eur Radiol 29:707–715PubMed Ryuge M, Hara M, Hiroe T et al (2019) Mechanisms of recurrent haemoptysis after super-selective bronchial artery coil embolisation: a single-centre retrospective observational study. Eur Radiol 29:707–715PubMed
6.
go back to reference Takx RA, Vliegenthart R, Mohamed Hoesein FA et al (2015) Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON study. Eur Radiol 25:65–71PubMed Takx RA, Vliegenthart R, Mohamed Hoesein FA et al (2015) Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON study. Eur Radiol 25:65–71PubMed
7.
go back to reference Waterton JC, Ho M, Nordenmark LH et al (2017) Repeatability and response to therapy of dynamic contrast-enhanced magnetic resonance imaging biomarkers in rheumatoid arthritis in a large multicentre trial setting. Eur Radiol 27:3662–3668PubMedPubMedCentral Waterton JC, Ho M, Nordenmark LH et al (2017) Repeatability and response to therapy of dynamic contrast-enhanced magnetic resonance imaging biomarkers in rheumatoid arthritis in a large multicentre trial setting. Eur Radiol 27:3662–3668PubMedPubMedCentral
8.
go back to reference Grimes DA, Schulz KF (2002) An overview of clinical research: the lay of the land. Lancet 359:57–61PubMed Grimes DA, Schulz KF (2002) An overview of clinical research: the lay of the land. Lancet 359:57–61PubMed
9.
go back to reference Funai EF, Rosenbush EJ, Lee MJ, Del Priore G (2001) Distribution of study designs in four major US journals of obstetrics and gynecology. Gynecol Obstet Invest 51:8–11PubMed Funai EF, Rosenbush EJ, Lee MJ, Del Priore G (2001) Distribution of study designs in four major US journals of obstetrics and gynecology. Gynecol Obstet Invest 51:8–11PubMed
10.
go back to reference Lv N, Kong Y, Mu L, Pan T, Xie Q, Zhao M (2016) Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial. Eur Radiol 26:3492–3499PubMed Lv N, Kong Y, Mu L, Pan T, Xie Q, Zhao M (2016) Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial. Eur Radiol 26:3492–3499PubMed
11.
go back to reference Atkin W, Dadswell E, Wooldrage K et al (2013) Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial. Lancet 381:1194–1202PubMed Atkin W, Dadswell E, Wooldrage K et al (2013) Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial. Lancet 381:1194–1202PubMed
12.
go back to reference Schwartz D, Lellouch J (1967) Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 20:637–648PubMed Schwartz D, Lellouch J (1967) Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 20:637–648PubMed
13.
go back to reference Thorpe KE, Zwarenstein M, Oxman AD et al (2009) A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 62:464–475PubMed Thorpe KE, Zwarenstein M, Oxman AD et al (2009) A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 62:464–475PubMed
14.
go back to reference Bossuyt PM, Olsen M, Hyde C, Cohen JF (2020) An analysis reveals differences between pragmatic and explanatory diagnostic accuracy studies. J Clin Epidemiol 117:29–35PubMed Bossuyt PM, Olsen M, Hyde C, Cohen JF (2020) An analysis reveals differences between pragmatic and explanatory diagnostic accuracy studies. J Clin Epidemiol 117:29–35PubMed
16.
go back to reference Britton A, McKee M, Black N, McPherson K, Sanderson C, Bain C (1999) Threats to applicability of randomised trials: exclusions and selective participation. J Health Serv Res Policy 4:112–121PubMed Britton A, McKee M, Black N, McPherson K, Sanderson C, Bain C (1999) Threats to applicability of randomised trials: exclusions and selective participation. J Health Serv Res Policy 4:112–121PubMed
17.
go back to reference Ferrante di Ruffano L, Dinnes J, Sitch AJ, Hyde C, Deeks JJ (2017) Test-treatment RCTs are susceptible to bias: a review of the methodological quality of randomized trials that evaluate diagnostic tests. BMC Med Res Methodol 17:35PubMedPubMedCentral Ferrante di Ruffano L, Dinnes J, Sitch AJ, Hyde C, Deeks JJ (2017) Test-treatment RCTs are susceptible to bias: a review of the methodological quality of randomized trials that evaluate diagnostic tests. BMC Med Res Methodol 17:35PubMedPubMedCentral
18.
go back to reference Bossuyt PM, Reitsma JB, Bruns DE et al (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Radiology 277:826–832PubMed Bossuyt PM, Reitsma JB, Bruns DE et al (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Radiology 277:826–832PubMed
19.
go back to reference Bossuyt PM, Irwig L, Craig J, Glasziou P (2006) Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ 332:1089–1092PubMedPubMedCentral Bossuyt PM, Irwig L, Craig J, Glasziou P (2006) Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ 332:1089–1092PubMedPubMedCentral
20.
go back to reference Taylor SA, Mallett S, Beare S et al (2019) Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective streamline C trial. Lancet Gastroenterol Hepatol 4:529–537PubMedPubMedCentral Taylor SA, Mallett S, Beare S et al (2019) Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective streamline C trial. Lancet Gastroenterol Hepatol 4:529–537PubMedPubMedCentral
21.
go back to reference Taylor SA, Mallett S, Bhatnagar G et al (2018) Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn’s disease (METRIC): a multicentre trial. Lancet Gastroenterol Hepatol 3:548–558PubMedPubMedCentral Taylor SA, Mallett S, Bhatnagar G et al (2018) Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn’s disease (METRIC): a multicentre trial. Lancet Gastroenterol Hepatol 3:548–558PubMedPubMedCentral
22.
go back to reference Dehmoobad Sharifabadi A, Leeflang M, Treanor L et al (2019) Comparative reviews of diagnostic test accuracy in imaging research: evaluation of current practices. Eur Radiol 29:5386–5394PubMed Dehmoobad Sharifabadi A, Leeflang M, Treanor L et al (2019) Comparative reviews of diagnostic test accuracy in imaging research: evaluation of current practices. Eur Radiol 29:5386–5394PubMed
23.
go back to reference Obuchowski NA, Beiden SV, Berbaum KS et al (2004) Multireader, multicase receiver operating characteristic analysis: an empirical comparison of five methods. Acad Radiol 11:980–995PubMed Obuchowski NA, Beiden SV, Berbaum KS et al (2004) Multireader, multicase receiver operating characteristic analysis: an empirical comparison of five methods. Acad Radiol 11:980–995PubMed
24.
go back to reference Lalji UC, Houben IP, Prevos R et al (2016) Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study. Eur Radiol 26:4371–4379PubMedPubMedCentral Lalji UC, Houben IP, Prevos R et al (2016) Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study. Eur Radiol 26:4371–4379PubMedPubMedCentral
25.
go back to reference Kim HG, Shin HJ, Kim YH et al (2015) Quantitative computed tomography assessment of graft-versus-host disease-related bronchiolitis obliterans in children: a pilot feasibility study. Eur Radiol 25:2931–2936PubMed Kim HG, Shin HJ, Kim YH et al (2015) Quantitative computed tomography assessment of graft-versus-host disease-related bronchiolitis obliterans in children: a pilot feasibility study. Eur Radiol 25:2931–2936PubMed
27.
28.
go back to reference Craig P, Dieppe P, Macintyre S et al (2008) Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 337:a1655PubMedPubMedCentral Craig P, Dieppe P, Macintyre S et al (2008) Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 337:a1655PubMedPubMedCentral
29.
go back to reference Takeuchi M, Wakao N, Hirasawa A et al (2017) Ultrasonography has a diagnostic value in the assessment of cervical radiculopathy: a prospective pilot study. Eur Radiol 27:3467–3473PubMedPubMedCentral Takeuchi M, Wakao N, Hirasawa A et al (2017) Ultrasonography has a diagnostic value in the assessment of cervical radiculopathy: a prospective pilot study. Eur Radiol 27:3467–3473PubMedPubMedCentral
30.
go back to reference Julious SA (2004) Sample sizes for clinical trials with normal data. Stat Med 23:1921–1986PubMed Julious SA (2004) Sample sizes for clinical trials with normal data. Stat Med 23:1921–1986PubMed
31.
go back to reference Stallard N (2012) Optimal sample sizes for phase II clinical trials and pilot studies. Stat Med 31:1031–1042PubMed Stallard N (2012) Optimal sample sizes for phase II clinical trials and pilot studies. Stat Med 31:1031–1042PubMed
34.
go back to reference Halpern SD, Karlawish JH, Berlin JA (2002) The continuing unethical conduct of underpowered clinical trials. JAMA 288:358–362PubMed Halpern SD, Karlawish JH, Berlin JA (2002) The continuing unethical conduct of underpowered clinical trials. JAMA 288:358–362PubMed
35.
go back to reference Grimes DA, Schulz KF (2002) Cohort studies: marching towards outcomes. Lancet 359:341–345PubMed Grimes DA, Schulz KF (2002) Cohort studies: marching towards outcomes. Lancet 359:341–345PubMed
36.
go back to reference Schulz KF, Grimes DA (2002) Case-control studies: research in reverse. Lancet 359:431–434PubMed Schulz KF, Grimes DA (2002) Case-control studies: research in reverse. Lancet 359:431–434PubMed
37.
go back to reference Darrah TH, Prutsman-Pfeiffer JJ, Poreda RJ, Ellen Campbell M, Hauschka PV, Hannigan RE (2009) Incorporation of excess gadolinium into human bone from medical contrast agents. Metallomics 1:479–488PubMed Darrah TH, Prutsman-Pfeiffer JJ, Poreda RJ, Ellen Campbell M, Hauschka PV, Hannigan RE (2009) Incorporation of excess gadolinium into human bone from medical contrast agents. Metallomics 1:479–488PubMed
38.
go back to reference Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM (2005) Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem 51:1335–1341PubMed Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM (2005) Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem 51:1335–1341PubMed
39.
go back to reference Gomez-Saez N, Gonzalez-Alvarez I, Vilar J et al (2014) Prevalence and variables associated with solitary pulmonary nodules in a routine clinic-based population: a cross-sectional study. Eur Radiol 24:2174–2182PubMedPubMedCentral Gomez-Saez N, Gonzalez-Alvarez I, Vilar J et al (2014) Prevalence and variables associated with solitary pulmonary nodules in a routine clinic-based population: a cross-sectional study. Eur Radiol 24:2174–2182PubMedPubMedCentral
41.
go back to reference Lucas NP, Macaskill P, Irwig L, Bogduk N (2010) The development of a quality appraisal tool for studies of diagnostic reliability (QAREL). J Clin Epidemiol 63:854–861PubMed Lucas NP, Macaskill P, Irwig L, Bogduk N (2010) The development of a quality appraisal tool for studies of diagnostic reliability (QAREL). J Clin Epidemiol 63:854–861PubMed
42.
go back to reference Chalkidou A, O’Doherty MJ, Marsden PK (2015) False discovery rates in PET and CT studies with texture features: a systematic review. PLoS One 10:e0124165PubMedPubMedCentral Chalkidou A, O’Doherty MJ, Marsden PK (2015) False discovery rates in PET and CT studies with texture features: a systematic review. PLoS One 10:e0124165PubMedPubMedCentral
43.
go back to reference Ioannidis JPA, Bossuyt PMM (2017) Waste, leaks, and failures in the biomarker pipeline. Clin Chem 63:963–972PubMed Ioannidis JPA, Bossuyt PMM (2017) Waste, leaks, and failures in the biomarker pipeline. Clin Chem 63:963–972PubMed
44.
45.
go back to reference Cooper LS, Chalmers TC, McCally M, Berrier J, Sacks HS (1988) The poor quality of early evaluations of magnetic resonance imaging. JAMA 259:3277–3280PubMed Cooper LS, Chalmers TC, McCally M, Berrier J, Sacks HS (1988) The poor quality of early evaluations of magnetic resonance imaging. JAMA 259:3277–3280PubMed
46.
go back to reference Smidt N, Rutjes AW, van der Windt DA et al (2005) Quality of reporting of diagnostic accuracy studies. Radiology 235:347–353PubMed Smidt N, Rutjes AW, van der Windt DA et al (2005) Quality of reporting of diagnostic accuracy studies. Radiology 235:347–353PubMed
Metadata
Title
How to avoid describing your radiological research study incorrectly
Authors
Steve Halligan
Shedrack F. Kenis
Oshaani Abeyakoon
Andrew A. O. Plumb
Susan Mallett
Publication date
01-08-2020
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 8/2020
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-06720-0

Other articles of this Issue 8/2020

European Radiology 8/2020 Go to the issue